Ion pair skin transport of a zwitterionic drug, cephalexin

被引:47
作者
Hatanaka, T [1 ]
Kamon, T [1 ]
Morigaki, S [1 ]
Katayama, K [1 ]
Koizumi, T [1 ]
机构
[1] Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan
关键词
ion pair; skin transport; zwitterionic drug; counter ion; cephalexin;
D O I
10.1016/S0168-3659(99)00259-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The ion pair skin transport of cephalexin was investigated using various counter ions and solvents. The permeability of cephalexin was enhanced by I-alkylsulfonates (ASs) at pH 3.0 and by tetraalkylammoniums (AAs) at pH 7.0; the enhancing ratio increased with the number of carbon atoms in their alkyl chains. The corresponding effects of these additives were observed on the partitioning of cephalexin. Most of the additives did not affect the skin transport of D-mannitol and cortisone. These results suggest that the enhanced transport of cephalexin results from the ion pair formation with additives. Although ASs increased the partitioning of cephalexin above that of AAs, the transport enhancement effect of ASs was lower than AAs having the same number of carbon atoms in their alkyl chains, indicating higher diffusivity of the ion pairs with AAs in skin. Moreover, the transport enhancement by AAs increased even more when ethanol-buffer solutions were used as solvents. The conductivity measurement of dissolving solutes in donor solvents showed that the further enhancement might be caused by the increasing ion pair formation in solvents with low dielectric constants. To obtain the maximum enhancement of skin transport of zwitterionic drugs via ion pair concept, one should select a counter ion having high lipophilicity and small volume, and a solvent with suitable pH and low dielectric constant. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 27 条
[1]   EFFECT OF ION-PAIRING ON 1-OCTANOL-WATER PARTITIONING OF PEPTIDE DRUGS .1. THE NONAPEPTIDE LEUPROLIDE ACETATE [J].
ADJEI, A ;
RAO, S ;
GARREN, J ;
MENON, G ;
VADNERE, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 90 (02) :141-149
[2]   SURFACTANT EFFECTS IN PERCUTANEOUS-ABSORPTION .1. EFFECTS ON THE TRANSDERMAL FLUX OF METHYL NICOTINATE [J].
ASHTON, P ;
WALTERS, KA ;
BRAIN, KR ;
HADGRAFT, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :261-264
[3]   CONTRIBUTIONS OF DRUG SOLUBILIZATION, PARTITIONING, BARRIER DISRUPTION, AND SOLVENT PERMEATION TO THE ENHANCEMENT OF SKIN PERMEATION OF VARIOUS COMPOUNDS WITH FATTY-ACIDS AND AMINES [J].
AUNGST, BJ ;
BLAKE, JA ;
HUSSAIN, MA .
PHARMACEUTICAL RESEARCH, 1990, 7 (07) :712-718
[4]   IN-VITRO EVALUATION OF A SERIES OF SODIUM CARBOXYLATES AS DERMAL PENETRATION ENHANCERS [J].
CUMMING, KI ;
WINFIELD, AJ .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 108 (02) :141-148
[5]  
GHANEM A-H, 1987, Journal of Controlled Release, V6, P75, DOI 10.1016/0168-3659(87)90065-4
[6]   PHYSICOCHEMICAL ASPECTS OF THE TRANSDERMAL DELIVERY OF BUPRANOLOL [J].
GREEN, PG ;
HADGRAFT, J ;
WOLFF, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (2-3) :265-269
[7]   FACILITATED PERCUTANEOUS-ABSORPTION - A COMPARISON AND EVALUATION OF 2 INVITRO MODELS [J].
HADGRAFT, J ;
WALTERS, KA ;
WOTTON, PK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :257-263
[8]   EFFECT OF PH ON THE SKIN PERMEABILITY OF A ZWITTERIONIC DRUG, CEPHALEXIN [J].
HATANAKA, T ;
MORIGAKI, S ;
AIBA, T ;
KATAYAMA, K ;
KOIZUMI, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 125 (02) :195-203
[9]   EFFECT OF VEHICLE ON THE SKIN PERMEABILITY OF DRUGS - POLYETHYLENE-GLYCOL 400-WATER AND ETHANOL-WATER BINARY SOLVENTS [J].
HATANAKA, T ;
SHIMOYAMA, M ;
SUGIBAYASHI, K ;
MORIMOTO, Y .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (03) :247-260
[10]   Influence of pH on skin permeation of amino acids [J].
Hatanaka, T ;
Kamon, T ;
Uozumi, C ;
Morigaki, S ;
Aiba, T ;
Katayama, K ;
Koizumi, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (07) :675-679